Xylamidine tosylate

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 412172

CAS#: 6443-40-9

Description: Xylamidine tosylate is a Serotonin inhibitor with reproductive effects


Chemical Structure

img
Xylamidine tosylate
CAS# 6443-40-9

Theoretical Analysis

MedKoo Cat#: 412172
Name: Xylamidine tosylate
CAS#: 6443-40-9
Chemical Formula: C26H32N2O5S
Exact Mass: 484.20
Molecular Weight: 484.610
Elemental Analysis: C, 64.44; H, 6.66; N, 5.78; O, 16.51; S, 6.62

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Xylamidine tosylate; BW545C64; BW-545C64; BW 545C64

IUPAC/Chemical Name: Acetamidine, N-(2-(m-methoxyphenoxy)propyl)-2-(m-tolyl)-, mono-p-toluenesulfonate

InChi Key: FRJLUWKYXWADTA-UHFFFAOYSA-N

InChi Code: InChI=1S/C19H24N2O2.C7H8O3S/c1-14-6-4-7-16(10-14)11-19(20)21-13-15(2)23-18-9-5-8-17(12-18)22-3;1-6-2-4-7(5-3-6)11(8,9)10/h4-10,12,15H,11,13H2,1-3H3,(H2,20,21);2-5H,1H3,(H,8,9,10)

SMILES Code: N=C(NCC(OC1=CC=CC(OC)=C1)C)CC2=CC=CC(C)=C2.CC3=CC=C(S(=O)(O)=O)C=C3

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 484.61 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Ishigami T, Yoshioka K, Karicheti V, Marson L. A role for peripheral 5-HT2 receptors in serotonin-induced facilitation of the expulsion phase of ejaculation in male rats. J Sex Med. 2013 Nov;10(11):2688-702. doi: 10.1111/jsm.12306. Epub 2013 Sep 12. PMID: 24024794.

2: Lacolley P, Owen JR, Sandock K, Lewis TH, Bates JN, Robertson TP, Lewis SJ. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors. Neuroscience. 2006 Nov 17;143(1):273-87. doi: 10.1016/j.neuroscience.2006.07.032. Epub 2006 Oct 9. PMID: 17029799.

3: Owen JR, Bates JN, Lewis SJ. Differential effects of nitroblue tetrazolium on the hemodynamic responses elicited by activation of alpha1-adrenoceptors and 5-HT2 receptors in conscious rats. Eur J Pharmacol. 2006 Mar 27;535(1-3):248-52. doi: 10.1016/j.ejphar.2006.01.060. Epub 2006 Mar 9. PMID: 16527267.

4: Sipe K, Leventhal L, Burroughs K, Cosmi S, Johnston GH, Deecher DC. Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction. Brain Res. 2004 Dec 3;1028(2):191-202. doi: 10.1016/j.brainres.2004.09.012. PMID: 15527744.

5: Dave KD, Quinn JL, Harvey JA, Aloyo VJ. Role of central 5-HT2 receptors in mediating head bobs and body shakes in the rabbit. Pharmacol Biochem Behav. 2004 Mar;77(3):623-9. doi: 10.1016/j.pbb.2003.12.017. PMID: 15006475.

6: Johnson KW, Nelson DL, Dieckman DK, Wainscott DB, Lucaites VL, Audia JE, Owton WM, Phebus LA. Neurogenic dural protein extravasation induced by meta- chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation. Cephalalgia. 2003 Mar;23(2):117-23. doi: 10.1046/j.1468-2982.2003.00464.x. PMID: 12603368.

7: Yamada J, Sugimoto Y, Yoshikawa T, Horisaka K. Hyperglycemia induced by the 5-HT receptor agonist, 5-methoxytryptamine, in rats: involvement of the peripheral 5-HT2A receptor. Eur J Pharmacol. 1997 Apr 4;323(2-3):235-40. doi: 10.1016/s0014-2999(97)00029-0. PMID: 9128844.

8: Danuser H, Thor KB. Spinal 5-HT2 receptor-mediated facilitation of pudendal nerve reflexes in the anaesthetized cat. Br J Pharmacol. 1996 May;118(1):150-4. doi: 10.1111/j.1476-5381.1996.tb15378.x. PMID: 8733588; PMCID: PMC1909481.

9: Chaouche-Teyara K, Fournier B, Safar M, Dabiré H. Systemic and regional haemodynamic effects of 1-(2,5-dimethoxy-4-iodo-phenyl)-2-aminopropane (DOI) and alpha-methyl-5-HT, in the anaesthetised rat. Clin Exp Hypertens. 1994 Nov;16(6):779-98. doi: 10.3109/10641969409078025. PMID: 7858559.

10: Zabik JE, Sprague JE, Binkerd K. Central and peripheral components of the inhibitory actions of 5-HTP on ethanol consumption in the rat. Pharmacol Biochem Behav. 1994 Mar;47(3):547-51. doi: 10.1016/0091-3057(94)90157-0. PMID: 8208773.

11: Eberle-Wang K, Braun BT, Simansky KJ. Serotonin contracts the isolated rat pylorus via a 5-HT2-like receptor. Am J Physiol. 1994 Jan;266(1 Pt 2):R284-91. doi: 10.1152/ajpregu.1994.266.1.R284. PMID: 8304552.

12: Lawton CL, Blundell JE. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI. Pharmacol Biochem Behav. 1993 Oct;46(2):349-60. doi: 10.1016/0091-3057(93)90363-x. PMID: 8265689.

13: Bailey SP, Davis JM, Ahlborn EN. Serotonergic agonists and antagonists affect endurance performance in the rat. Int J Sports Med. 1993 Aug;14(6):330-3. doi: 10.1055/s-2007-1021187. PMID: 8407063.

14: Chaouche-Teyara K, Dabiré H, Fournier B, Safar M. Participation périphérique et centrale aux effets hémodynamiques de la stimulation des récepteurs sérotoninergiques2 [Peripheral and central participation in hemodynamic effects of serotonin2 receptor stimulation]. Arch Mal Coeur Vaiss. 1993 Aug;86(8):1257-61. French. PMID: 8129539.

15: Grignaschi G, Mantelli B, Samanin R. The hypophagic effect of restraint stress in rats can be mediated by 5-HT2 receptors in the paraventricular nucleus of the hypothalamus. Neurosci Lett. 1993 Apr 2;152(1-2):103-6. doi: 10.1016/0304-3940(93)90494-6. PMID: 8515859.

16: Pérgola PE, Sved AF, Voogt JL, Alper RH. Effect of serotonin on vasopressin release: a comparison to corticosterone, prolactin and renin. Neuroendocrinology. 1993 Mar;57(3):550-8. doi: 10.1159/000126404. PMID: 8321422.

17: Meller ST, Lewis SJ, Brody MJ, Gebhart GF. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes. Brain Res. 1992 Jul 10;585(1-2):71-86. doi: 10.1016/0006-8993(92)91192-h. PMID: 1511336.

18: Bond EF, Heitkemper MM, Gruver MK. Mediation of thyrotropin-releasing hormone induced gastric motility increases in developing rats. Eur J Pharmacol. 1992 Jul 7;217(2-3):127-35. doi: 10.1016/0014-2999(92)90831-n. PMID: 1425933.

19: Yamada J, Sugimoto Y, Kimura I, Watanabe Y, Takeuchi N, Horisaka K. Hyperglucagonemia induced in mice by tryptamine: involvement of the peripheral 5-HT2 receptors. Eur J Pharmacol. 1992 Jun 5;216(2):307-10. doi: 10.1016/0014-2999(92)90375-e. PMID: 1397014.

20: Grignaschi G, Samanin R. Role of serotonin and catecholamines in brain in the feeding suppressant effect of fluoxetine. Neuropharmacology. 1992 May;31(5):445-9. doi: 10.1016/0028-3908(92)90082-z. PMID: 1528396.